Wockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...

Zydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...

Vitamin C supplements may reduce cancer risk linked to processed meat nitrates, according to new cancer research from the University of Wat...

The Competition Commission of India observed that patients in Delhi-NCR super-speciality hospitals often depend on in-house services, creat...

Imagine navigating the wild terrains of Africa or Asia, where cobras lurk with their potent venom that disrupts the nervous system, leading...

Jharkhand has set a benchmark by maintaining its segment of the Ganga river pristine for seven straight years. This achievement stems from ...

Scientists are rethinking snake venom evolution. Previously, complexity was seen as superior. New research shows snakes simplify venom for ...

Scientists have found blood vessels inside Tyrannosaurus rex bones. This discovery changes how we understand fossils. It shows that delicat...

Vitamin B12 and healthy aging are now linked by striking new evidence from Cornell University. A landmark study published in the Journal of...

Scientists have discovered Greenland sharks live for centuries. A 2016 study used radiocarbon dating of eye lenses to determine their age. ...

Hair growth originates from follicles beneath the scalp, not the ends. While trimming doesn't accelerate growth, it's crucial for preventin...

Bananas ripen naturally with ethylene, developing flavor and texture. Artificial methods use chemicals like calcium carbide, speeding up th...

Neccon Power's initial issue will see sale of up to 1,27,00,000 and Narmada Bio-chem will offer 72,00,000 equity shares according to the dr...

Zydus Cadila has acquired 100% stake in Mumbai-based Biochem Pharmaceuticals for an undisclosed amount.

Biochem has a presence in various therapeutic segments, including antibiotics, cardiovascular, anti-diabetics and oncology.

The deal is expected to be valued at Rs 300-450 cr and will boost Biochem's revenue growth. In fiscal 2009-10, Biochem reported revenues of...

Shasun Pharmaceuticals Ltd has entered into a joint venture with US based Nanoparticle Biochem Inc to explore opportunities in the field of...